Ghosh Iman, Adams Danielle, Auguste Peter, Brown Anna, Chaplin Eddie, Flynn Samantha, Gauly Julia, Gill Paramjit, Langdon Peter E, Mahon David, Martin Kerry, Patterson Stephen, Sutherland Daniel, Tromans Samuel J, Chen Yen-Fu, Seers Kate
Centre for Evidence and Implementation Science, University of Birmingham, Birmingham, UK.
Warwick Applied Heath, University of Warwick, Coventry, UK.
BMJ Open. 2025 Sep 18;15(9):e090876. doi: 10.1136/bmjopen-2024-090876.
To explore the challenges experienced by people with intellectual disability, their carers and health and social care professionals when using and managing medication.
A synthesis of qualitative research using meta-ethnography.
We searched seven databases: MEDLINE, Embase, CINAHL, Science, Social Science and Conference Proceedings Citation Indices (Web of Science), Cochrane Library, PsycINFO and Proquest Dissertations and Theses from inception to September 2022 (updated in July 2023).
We included studies exploring the challenges and perceptions of people with intellectual disability, their carers and health and social care professionals regarding medication management and use.
We reviewed 7593 abstracts and 475 full texts, resulting in 45 included papers. Four major themes were identified: (1) Medication-related issues, (2) navigating autonomy and relationships, (3) knowledge and training needs and (4) inequalities in the healthcare system. We formulated a conceptual framework centred around people with intellectual disability and described the interconnectedness between them, their carers and health and social care professionals in the process of managing and using medication. We identified challenges that could be associated with the person, the medication and/or the context, along with a lack of understanding of these challenges and a lack of capability or resources to tackle them. We developed an overarching concept of 'collective collaboration' as a potential solution to prevent or mitigate problems related to medication use in people with intellectual disability.
The effective management of medication for people with intellectual disability requires a collaborative and holistic approach. By fostering person-centred care and shared decision-making, providing educational and practical support, and nurturing strong relationships between all partners involved to form a collective collaboration surrounding people with intellectual disability, improved medication adherence and optimised therapeutic outcomes can be achieved.
CRD42022362903.
探讨智障人士及其照料者以及健康和社会护理专业人员在用药和管理药物时所面临的挑战。
采用元民族志的定性研究综合分析。
我们检索了七个数据库:MEDLINE、Embase、CINAHL、科学引文索引、社会科学引文索引和会议论文引文索引(科学网)、Cochrane图书馆、PsycINFO以及Proquest博硕士论文数据库,检索时间从建库至2022年9月(2023年7月更新)。
我们纳入了探讨智障人士及其照料者以及健康和社会护理专业人员在药物管理和使用方面的挑战及看法的研究。
我们审查了7593篇摘要和475篇全文,最终纳入45篇论文。确定了四个主要主题:(1)与药物相关的问题,(2)自主性与关系的协调,(3)知识和培训需求,以及(4)医疗保健系统中的不平等。我们构建了一个以智障人士为中心的概念框架,描述了他们、他们的照料者以及健康和社会护理专业人员在药物管理和使用过程中的相互联系。我们确定了可能与人、药物和/或环境相关的挑战,以及对这些挑战缺乏理解以及应对这些挑战的能力或资源不足的问题。我们提出了“集体协作”这一总体概念,作为预防或减轻智障人士用药相关问题的潜在解决方案。
对智障人士进行有效的药物管理需要采取协作性的整体方法。通过促进以患者为中心的护理和共同决策,提供教育和实践支持,并培养所有相关伙伴之间的牢固关系,围绕智障人士形成集体协作,可以实现更好的药物依从性并优化治疗效果。
PROSPERO注册号:CRD42022362903。